Cargando…

Combination therapy for HCC: from CRISPR screening to the design of clinical therapies

Detalles Bibliográficos
Autores principales:	Wang, Yunguang, Kui, Ling, Wang, Guangchuan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Research Highlight
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8490435/ https://www.ncbi.nlm.nih.gov/pubmed/34608130 http://dx.doi.org/10.1038/s41392-021-00775-1

Ejemplares similares

Decoding γδ T cell anticancer therapies: integrating CRISPR screens with tumor organoids
por: Zhou, Jian, et al.
Publicado: (2023)

The paradox of immunotherapy in NASH-HCC
por: Peng, Yao, et al.
Publicado: (2021)

A CRISPR design for next-generation antimicrobials
por: Beisel, Chase L, et al.
Publicado: (2014)

Dietary reprogram of macrophages for cell competition: a promising strategy for malignant cancer control
por: Chen, Jian, et al.
Publicado: (2023)

On the road to epigenetic therapy
por: Walton, Emma L.
Publicado: (2016)

The first human trial of CRISPR-based cell therapy clears safety concerns as new treatment for late-stage lung cancer
por: He, Shenghui
Publicado: (2020)

CRISPR sabotage
por: van der Oost, John, et al.
Publicado: (2015)

Who Has Therapy-Related AML?
por: Gale, Robert Peter, et al.
Publicado: (2017)

Towards gene therapy for IPEX syndrome
por: Borna, Simon, et al.
Publicado: (2022)

Combination therapy using GDNF and cell transplant in Parkinson’s disease
por: Xiao, Bin, et al.
Publicado: (2022)

Protein stability regulators screening assay (Pro-SRSA): protein degradation meets the CRISPR–Cas9 library
por: Wu, Yuanzhong, et al.
Publicado: (2016)

Development of Antibody‐Directed Therapies: Quo Vadis?
por: Rodrigues, Tiago, et al.
Publicado: (2018)

Margetuximab: An active alternative for later‐line therapy in patients with HER2‐positive advanced breast cancer
por: Zhou, Yunxiang, et al.
Publicado: (2023)

Modulating serine palmitoyltransferase‐deoxysphingolipid axis in cancer therapy
por: Xiang, Yuancai, et al.
Publicado: (2020)

Neurotrophic factor therapy for Parkinson's disease: past, present and future
por: Sullivan, Aideen M., et al.
Publicado: (2016)

Boosting plant immunity with CRISPR/Cas
por: Chaparro-Garcia, Angela, et al.
Publicado: (2015)

The continuously evolving CRISPR barcoding toolbox
por: Gaj, Thomas, et al.
Publicado: (2018)

CRISPR enables directed evolution in plants
por: Zhang, Yingxiao, et al.
Publicado: (2019)

A CRISPR way to engineer the human genome
por: Ramalingam, Sivaprakash, et al.
Publicado: (2013)

Understanding and repurposing CRISPR-mediated alternative splicing
por: Smith, Jordan L., et al.
Publicado: (2018)

Artificial intelligence-assisted niacin skin flush screening in early psychosis identification and prediction
por: Chen, Tao, et al.
Publicado: (2022)

A combination therapy for KRAS-mutant lung cancer by targeting synthetic lethal partners of mutant KRAS
por: Pang, Xiufeng, et al.
Publicado: (2016)

CRISPR base editor treats premature-aging syndrome
por: Lin, Ping, et al.
Publicado: (2021)

Using CRISPR to understand how cancer mutations happen
por: Rogers, Eve H.
Publicado: (2021)

Research highlights for issue 6: the CRISPR/Cas revolution
por: Koskella, Britt
Publicado: (2015)

CRISPR-mediated genome editing of Plasmodium falciparum malaria parasites
por: Lee, Marcus CS, et al.
Publicado: (2014)

Unexpected consequences: exon skipping caused by CRISPR-generated mutations
por: Sharpe, Joshua J., et al.
Publicado: (2017)

On demand CRISPR-mediated RNA N6-methyladenosine editing
por: Xu, Ying, et al.
Publicado: (2022)

The best protection is early detection: Fostering timely and accurate screening
por: Kattner, Aila Akosua
Publicado: (2021)

Personalizing carbamazepine therapy
por: Mushiroda, Taisei, et al.
Publicado: (2011)

The Cpf1 CRISPR-Cas protein expands genome-editing tools
por: Fagerlund, Robert D., et al.
Publicado: (2015)

Redefining mouse transgenesis with CRISPR/Cas9 genome editing technology
por: Burgio, Gaetan
Publicado: (2018)

CRISPRing the hypertrophic cardiomyopathy: correcting one pathogenic variant at a time
por: Afzal, Junaid, et al.
Publicado: (2023)

Design of a tailor‐made platform for syngas bioconversion into polyhydroxybutyrate
por: Narancic, Tanja, et al.
Publicado: (2017)

CRISPR-mediated RNA base editing: a promising strategy to rescue deafness
por: Liu, Wenyi, et al.
Publicado: (2023)

The power of unbiased phenotypic screens – cellulose as a first receptor for the Schitoviridae phage S6 of Erwinia amylovora
por: Römling, Ute
Publicado: (2022)

Multi-cancer blood testing combined with PET-CT: road for hope to screen for cancer and guide intervention
por: Jiang, Tao, et al.
Publicado: (2020)

Targeted next-generation sequencing for routine clinical screening of mutations
por: Weaver, Jamie MJ, et al.
Publicado: (2011)

Insights from the degradation mechanism of cyclin D into targeted therapy of the cancer cell cycle
por: Caudron-Herger, Maiwen, et al.
Publicado: (2021)

Pop in, pop out: a novel gene-targeting strategy for use with CRISPR-Cas9
por: Kühn, Ralf, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_4afkcskl1sd8flatvibonqmtu9